KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Cash: 2012-2024

Historic Change in Cash for Travere Therapeutics (TVTX) over the last 13 years, with Dec 2024 value amounting to $359,000.

  • Travere Therapeutics' Change in Cash rose 768.77% to $35.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.5 million, marking a year-over-year increase of 169.11%. This contributed to the annual value of $359,000 for FY2024, which is 110.22% up from last year.
  • According to the latest figures from FY2024, Travere Therapeutics' Change in Cash is $359,000, which was up 110.22% from -$3.5 million recorded in FY2023.
  • In the past 5 years, Travere Therapeutics' Change in Cash ranged from a high of $81.0 million in FY2021 and a low of -$104.1 million during FY2022.
  • Over the past 3 years, Travere Therapeutics' median Change in Cash value was -$3.5 million (recorded in 2023), while the average stood at -$35.7 million.
  • In the last 5 years, Travere Therapeutics' Change in Cash soared by 262.56% in 2021 and then tumbled by 228.51% in 2022.
  • Travere Therapeutics' Change in Cash (Yearly) stood at $22.3 million in 2020, then surged by 262.56% to $81.0 million in 2021, then slumped by 228.51% to -$104.1 million in 2022, then soared by 96.63% to -$3.5 million in 2023, then skyrocketed by 110.22% to $359,000 in 2024.